• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·300244.SZ
Share

Dian Diagnostics Group Co.,Ltd. Stocks

CN¥ 19.79Last Updated 12.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.54B

CN¥ 19.79
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of medical diagnostic services within China. The company delivers comprehensive diagnostic solutions to a broad spectrum of healthcare organizations, including general and specialized hospitals, community health centers, township clinics, physical examination facilities, and disease prevention and control agencies. Supporting its extensive operations, Dian Diagnostics manages a global network of 40 advanced chain laboratories. Beyond its core diagnostic offerings, the company is also deeply involved in the research, development, and manufacturing of in vitro diagnostic reagents, along with associated equipment and consumables. Furthermore, it plays a crucial role in the medical supply chain, facilitating the provision of various products such as medical equipment, pharmaceuticals, clinical samples, biological products, finished blood products, live animals, chemical compounds, and diagnostic reagents. Dian Diagnostics also specializes in comprehensive cold chain logistics, which includes transportation, warehousing, product sales, and technical support services for temperature-sensitive medical goods. Founded in 2001, the company is headquartered in Hangzhou, China. It adopted its current name, Dian Diagnostics Group Co.,Ltd., in November 2017, having previously operated as Zhejiang DIAN Diagnostics Co., Ltd.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 300244.SZ is 19 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026